Lysenin, a novel sphingomyelin-specific binding protein.
Lysenin, a novel 41-kDa protein purified from coelomic fluid of the earthworm Eisenia foetida, induced erythrocyte lysis. Preincubation of lysenin with vesicles containing sphingomyelin inhibited lysenin-induced hemolysis completely, whereas vesicles containing phospholipids other than sphingomyelin showed no inhibitory activity, suggesting that lysenin bound specifically to sphingomyelin on erythrocyte membranes. The specific binding of lysenin to sphingomyelin was confirmed by enzyme-linked immunosorbent assay, TLC immunostaining, and liposome lysis assay. In these assays, lysenin bound specifically to sphingomyelin and did not show any cross-reaction with other phospholipids including sphingomyelin analogs such as sphingosine, ceramide, and sphingosylphosphorylcholine, indicating that it recognized a precise molecular structure of sphingomyelin. Kinetic analysis of the lysenin-sphingomyelin interaction by surface plasmon resonance measurements using BIAcoreTM system showed that lysenin associated with membrane surfaces composed of sphingomyelin (kon = 3.2 x 10(4) M-1 s-1) and dissociated extremely slowly (koff = 1.7 x 10(-4) s-1), giving a low dissociation constant (KD = 5.3 x 10(-9) M). Incorporation of cholesterol into the sphingomyelin membrane significantly increased the total amount of lysenin bound to the membrane, whereas it did not change the kinetic parameters of the lysenin-membrane interaction, suggesting that lysenin specifically recognized sphingomyelin and cholesterol incorporation changed the topological distribution of sphingomyelin in the membranes, thereby increasing the accessibility of sphingomyelin to lysenin. Immunofluorescence staining of fibroblasts derived from a patient with Niemann-Pick disease type A showed that lysenin stained the surfaces of the fibroblasts uniformly, whereas intense lysosomal staining was observed when the cells were permeabilized by digitonin treatment. Preincubation of lysenin with vesicles containing sphingomyelin abolished lysenin immunostaining. This study demonstrated that lysenin bound specifically to sphingomyelin on cellular membranes and should be a useful tool to probe the molecular motion and function of sphingomyelin in biological membranes.
Yamaji
A
A
Department of Inflammation Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Sekizawa
Y
Y
Emoto
K
K
Sakuraba
H
H
Inoue
K
K
Kobayashi
H
H
Umeda
M
M
D000818:Animals; D015374:Biosensing Techniques; D001826:Body Fluids / Q000737:chemistry; D002784:Cholesterol / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D004910:Erythrocyte Membrane / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects; D005347:Fibroblasts / Q000737:chemistry; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D007700:Kinetics; D008081:Liposomes; D008297:Male; D009542:Niemann-Pick Diseases / Q000473:pathology; D009835:Oligochaeta / Q000737:chemistry*; D011485:Protein Binding / Q000187:drug effects; D011506:Proteins / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats; D012756:Sheep; D013109:Sphingomyelins / Q000378:metabolism*; D014118:Toxins, Biological
D008081:Liposomes; D011506:Proteins; D013109:Sphingomyelins; D014118:Toxins, Biological; C107040:lysenin; D002784:Cholesterol